
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Phlexglobal announced an important industry advisory around the new European Medicines Agency guidance on Trial Master Files that took effect on June 6.
To learn more about the advisory, click






